3 June 2020 - The Trump administration has selected five companies, including Moderna, AstraZeneca and Pfizer, as the most likely candidates to produce a vaccine for the novel coronavirus, the New York Times reported on Wednesday, citing senior officials.
The other companies are Johnson & Johnson and Merck & Co, according to the paper.
The selected companies will get access to additional government funds, help in running clinical trials, and financial and logistical support, the paper reported.